trial
as of 2026-07-01Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection
NCTId NCT03390712
at a glance
Phase — · Unknown
Enrollment 328 (estimated)
Sponsored by Réseau de Santé Vitalité Health Network
Primary completion 2018-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
328 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2018-01-02
Primary completion
2018-09
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Réseau de Santé Vitalité Health NetworkLead Sponsor
Sites
4 total
Bathurst, CanadaCampbellton, CanadaEdmundston, CanadaMoncton, Canada
Facts & assertions
4 sourced
Enrollment
328
Phase
NA
Primary Completion Date
2018-09
Status
UNKNOWN
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication